Evidence map›Paper›PMID 30375511›Full record

ArticleCell death and differentiation2019

Chlamydia trachomatis fails to protect its growth niche against pro-apoptotic insults.

Barbara S Sixt, Carlos Núñez-Otero, Oliver Kepp, Raphael H Valdivia, Guido Kroemer

Open access · hybridAbstract read
In one paragraph

Article in Cell death and differentiation, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
1.9field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 24 citations in OpenAlex.

  1. Review
  2. Clinical and prognostic insights into Chlamydia trachomatis in pediatric acute respiratory infections: evidence from targeted next-generation sequencing of 5,021 cases.European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology · 2025
    Article
  3. mBio · 2024
    Article
  4. Review
  5. Prognostic Value of Anti-Journal of inflammation research · 2024
    Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. [Role of tumor necrosis factor-α inNan fang yi ke da xue xue bao = Journal of Southern Medical University · 2020
    Article
  13. Article
  14. Modulation of Host Cell Death and Lysis Are Required for the Release ofFrontiers in cellular and infection microbiology · 2020
    Article
  15. Review
  16. Article
  17. Review
  18. Clear Victory forFrontiers in microbiology · 2019
    Review
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 4 institutions in 3 countries.

Barbara S SixtLaboratory for Molecular Infection Medicine Sweden, Umeå Centre for Microbial Research, Department of Molecular Biology, Umeå University, 90187, Umeå, Sweden. barbara.sixt@umu.se.
Carlos Núñez-OteroLaboratory for Molecular Infection Medicine Sweden, Umeå Centre for Microbial Research, Department of Clinical Microbiology, Umeå University, 90185, Umeå, Sweden.
Oliver KeppINSERM U1138, Centre de Recherche des Cordeliers, 75006, Paris, France.
Raphael H ValdiviaDepartment of Molecular Genetics and Microbiology, Duke University School of Medicine, Durham, NC, 27710, USA.
Guido KroemerINSERM U1138, Centre de Recherche des Cordeliers, 75006, Paris, France. kroemer@orange.fr.
Umeå University · SEDuke University · USKarolinska Institutet · SEUniversité Paris Cité · FR

Funding

Forward and Reverse Genetics in ChlamydiaR01AI100759 · NIAID · DUKE UNIVERSITY · PI VALDIVIA, RAPHAEL H · 2012 to 2016
$2.2M
Data commons for 'omic, microscopy and analysis core facilitiesS10OD018164 · OD · DUKE UNIVERSITY · PI WRAY, GREGORY A. · 2014 to 2014
$598k
NIAID NIH HHS R01 AI100759NIH HHS S10 OD018164
6 · The paper itself

Abstract

Chlamydia trachomatis is an obligate intracellular bacterial agent responsible for ocular infections and sexually transmitted diseases. It has been postulated that Chlamydia inhibits apoptosis in host cells to maintain an intact replicative niche until sufficient infectious progeny can be generated. Here we report that, while cells infected with C. trachomatis are protected from apoptosis at early and mid-stages of infection, they remain susceptible to the induction of other cell death modalities. By monitoring the fate of infected cells by time-lapse video microscopy and by analyzing host plasma membrane integrity and the activity of caspases, we determined that C. trachomatis-infected cells exposed to pro-apoptotic stimuli predominately died by a mechanism resembling necrosis. This necrotic death of infected cells occurred with kinetics similar to the induction of apoptosis in uninfected cells, indicating that C. trachomatis fails to considerably prolong the lifespan of its host cell when exposed to pro-apoptotic insults. Inhibitors of bacterial protein synthesis partially blocked necrotic death of infected cells, suggesting that the switch from apoptosis to necrosis relies on an active contribution of the bacteria. Tumor necrosis factor alpha (TNF-α)-mediated induction of necrosis in cells infected with C. trachomatis was not dependent on canonical regulators of necroptosis, such as RIPK1, RIPK3, or MLKL, yet was blocked by inhibition or depletion of CASP8. These results suggest that alternative signaling pathways regulate necrotic death in the context of C. trachomatis infections. Finally, consistent with the inability of C. trachomatis to preserve host cell viability, necrosis resulting from pro-apoptotic conditions significantly impaired production of infectious progeny. Taken together, our findings suggest that Chlamydia's anti-apoptotic activities are not sufficient to protect the pathogen's replicative niche.

Indexed as

ApoptosisAnti-Bacterial AgentsChlamydia trachomatisHeLa CellsHumansStaurosporineAnti-Bacterial AgentsStaurosporine

Identifiers

PMID30375511
PMCPMC6748135
OpenAlexW2899211597

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.